Time

Topic

0:11

Overview of career and current position

2:25

Joining the FDA

7:10

Founding the Degge Group (1988)

9:51

Very early ISPE meetings

10:43

First meeting in Minnesota

12:00

Becoming president of the society

13:22

The early days of ICPE

13:35

Early development of the science- less advanced

14:45

Potential for international growth

17:14

Evolution of poster presentations and workshops

19:30

Discipline viewed differently by industry, regulatory, and academia

20:00

PE gets embraced more widely as discipline

21:27

Making ISPE an international organization

21:55

Frank May sees need bring Asia to the table

23:00

Companies becoming multinational, natural follow-on to be more international

24:19

Fondest memories from the ICPE meetings

24:20

Intensity and intimacy of the meetings, ability to plan programs and research

25:32

Challenging the field in the early days of ISPE

26:20

Academic and NIH early attitudes about pharmacoepidemiology

28:03

The scholarship program

28:51

Wisdom to pass on to future leaders and members of ISPE

29:40

Impact of ISPE, personally and professionally

29:40

Part and parcel of life and career

30:20

Hope society continues to promote pharmacoepidemiology and medical product epidemiology, expanding field so it includes all medical products

31:14

Do you have any other comments you would like to make?

31:47

Governance model of society- inclusive, open, transparent- wonderful for the future and a model for other societies